California Public Employees Retirement System’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-29,400
Closed -$1.1M – 2548
2021
Q1
$1.1M Sell
29,400
-2,724
-8% -$114K ﹤0.01% 2425
2020
Q4
$1.07M Sell
32,124
-600
-2% -$24.3K ﹤0.01% 2429
2020
Q3
$1.2M Buy
32,724
+800
+3% +$27.7K ﹤0.01% 2145
2020
Q2
$1.05M Buy
31,924
+23,916
+299% +$919K ﹤0.01% 2205
2020
Q1
$207K Buy
+8,008
New +$268K ﹤0.01% 2838

Other funds holding PHAT

California Public Employees Retirement System's PHAT Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Phathom Pharmaceuticals (PHAT) in Q2 2021, closing a stake of 29,400 shares — an estimated $1.1M sold.

California Public Employees Retirement System first reported a position in PHAT in Q1 2020 and held it in 5 quarters. The position peaked at $1.2M in Q3 2020. 79 funds tracked by Wall St. Rank hold PHAT as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Phathom Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 29,400 Phathom Pharmaceuticals shares in Q2 2021, an estimated $1.1M.
  • California Public Employees Retirement System first reported a position in Phathom Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • California Public Employees Retirement System's Phathom Pharmaceuticals position peaked at $1.2M in Q3 2020.
  • 79 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.